In detail, CST3, GPX3, PON1, CFD, COMP and MRC1 level variations were confirmed using Western blotting on pooled healthy and staged (AJCC I–IV) CRC plasma samples (Fig. 5a). This evidence concerns the gene MRC1 and colorectal carcinoma.